| Cat. No. |
Product Name |
Information |
| PC-72805 |
N-0385
TMPRSS2 inhibitor
|
N-0385 (N 0385, Ms-Gln-Phe-Arg-kbt) is a potent, selective inhibitor of TMPRSS2 with IC50 of 1.9 nM |
| PC-72800 |
SSYA 10-001
SARS-CoV-2 Nsp13 inhibitor
|
SSYA 10-001 (DSHS00884, SSYA10-001) is a small molecule inhibitor of SARS-CoV-2 Nsp13 helicase with IC50 of 3.5 uM. |
| PC-72752 |
PF-00835231
3CLpro inhibitor
|
PF-00835231 (PF00835231) is a potent inhibitor of pan-coronavirus family 3CL pro (IC50=0.27 nM, SARS CoV-2), with selectivity over human host protease targets |
| PC-72751 |
PF-07304814
3CL pro inhibitor
|
PF-07304814 (PF 07304814, Lufotrelvir) is a phosphate prodrug of PF-00835231, which is a potent, selective inhibitor of pan-coronavirus family 3CL pro. |
| PC-72735 |
MCULE-5948770040
SARS-CoV-2 Mpro inhibitor
|
MCULE-5948770040 is a competitive noncovalent inhibitor of SARS-CoV-2 main protease (Mpro) with IC50 of 0.68 uM. |
| PC-72607 |
PF-07321332
SARS-CoV-2 Mpro inhibitor
|
PF-07321332 (Nirmatrelvir, Paxlovid) is the first, orally bioavailable SARS-CoV-2 main protease (Mpro) inhibitor with biochemical Ki of 3.11 nM. |
| PC-72518 |
Jun9-57-3R
Mpro inhibitor
|
Jun9-57-3R is a potent, selective, covalent SARS-CoV-2 Mpro inhibitor with IC50 of 0.05 uM. |
| PC-72517 |
Jun9-88-6R
Mpro inhibitor
|
Jun9-88-6R is a potent, selective, covalent SARS-CoV-2 Mpro inhibitor with IC50 of 0.08 uM. |
| PC-72516 |
Jun9-62-2R
Mpro inhibitor
|
Jun9-62-2R is a potent, selective, covalent SARS-CoV-2 Mpro inhibitor with IC50 of 0.43 uM. |
| PC-72437 |
MPI3
SARA-CoV2 Mpro inhibitor
|
MPI8 is a highly potent SARS-CoV-2 main protease (MPro) inhibitor with IC50 of 8.5 nM. |
| PC-72436 |
MPI5
SARA-CoV2 Mpro inhibitor
|
MPI8 is a highly potent SARS-CoV-2 main protease (MPro) inhibitor with IC50 of 33 nM, completely prevented the SARS-CoV-2-induced cytopathogenic effect in Vero E6 cells at 2.5-5 uM and A549 cells at 0.16-0.31 uM. |
| PC-72328 |
NSC 621601
SARS-CoV-2 entry inhibitor
|
NSC 621601 (Compound Q34) is a potent, specific inhibitor of SARS-CoV-2 cellular entry with IC50 of 15 uM. |
